메뉴 건너뛰기




Volumn 83, Issue 2, 2006, Pages 164-178

Current status of hematopoietic cell transplantation for adult patients with hematologic diseases and solid tumors in Japan

(21)  Imamura, Masahiro a   Asano, Shigetaka b   Harada, Mine c   Ikeda, Yasuo d   Kato, Koji e   Kato, Shunichi f   Kawa, Keisei g   Kojima, Seiji h   Morishima, Yasuo i   Morishita, Yoshihisa j   Nakahata, Tatsutoshi k   Okamura, Jun l   Okamoto, Shinichiro d   Shiobara, Shintaro m   Tanimoto, Mitsune n   Tsuchida, Masahiro o   Atsuta, Yoshiko h   Yamamoto, Kazuhito i   Tanaka, Junji a   Hamajima, Nobuyuki h   more..


Author keywords

Graft versus host disease; Hematologic malignancies; Hematopoietic cell transplantation; Overall survival; Solid tumors

Indexed keywords

BUSULFAN; CLADRIBINE; CYCLOSPORIN A; FLUDARABINE; HLA A ANTIGEN; HLA B ANTIGEN; HLA DR ANTIGEN; METHOTREXATE; TACROLIMUS;

EID: 33646823333     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.05134     Document Type: Article
Times cited : (17)

References (55)
  • 1
    • 0032697244 scopus 로고    scopus 로고
    • Bone marrow transplantation: A review
    • Thomas ED. Bone marrow transplantation: a review. Semin Hematol. 1999;36(suppl 7):95-103.
    • (1999) Semin Hematol , vol.36 , Issue.SUPPL. 7 , pp. 95-103
    • Thomas, E.D.1
  • 2
    • 0034585908 scopus 로고    scopus 로고
    • Haematopoietic stem-cell transplantation: Recent progress and future promise
    • Craddock C. Haematopoietic stem-cell transplantation: recent progress and future promise. Lancet Oncol. 2000;1:227-234.
    • (2000) Lancet Oncol , vol.1 , pp. 227-234
    • Craddock, C.1
  • 3
    • 11144333723 scopus 로고    scopus 로고
    • Stem-cell transplantation for the treatment of advanced solid tumors
    • Nieto Y, Jones RB, Shpall EL. Stem-cell transplantation for the treatment of advanced solid tumors. Springer Semin Immunopathol. 2004;26:31-56.
    • (2004) Springer Semin Immunopathol , vol.26 , pp. 31-56
    • Nieto, Y.1    Jones, R.B.2    Shpall, E.L.3
  • 4
    • 30944454875 scopus 로고    scopus 로고
    • Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: A report of the EBMT activity survey 2003
    • Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A. Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003. Bone Marrow Transplant. 2005;36:575-590.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 575-590
    • Gratwohl, A.1    Baldomero, H.2    Schmid, O.3    Horisberger, B.4    Bargetzi, M.5    Urbano-Ispizua, A.6
  • 5
    • 0033759545 scopus 로고    scopus 로고
    • Non-myeloablative stem cell transplants
    • Barrett J, Childs R. Non-myeloablative stem cell transplants. Br J Haematol. 2000;111:6-17.
    • (2000) Br J Haematol , vol.111 , pp. 6-17
    • Barrett, J.1    Childs, R.2
  • 6
    • 0042738792 scopus 로고    scopus 로고
    • Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000)
    • Kanda Y, Chiba S, Hirai H, et al. Allogeneic hematopoietic stem cell transplantation from family members other than HLA-identical siblings over the last decade (1991-2000). Blood. 2003;102:1541-1547.
    • (2003) Blood , vol.102 , pp. 1541-1547
    • Kanda, Y.1    Chiba, S.2    Hirai, H.3
  • 7
    • 10744227231 scopus 로고    scopus 로고
    • Unrelated bone marrow transplantation from non-Hodgkin lymphoma: A study from the Japan Marrow Donor Program
    • Izutsu K, Kanda Y, Ohno H, et al. Unrelated bone marrow transplantation from non-Hodgkin lymphoma: a study from the Japan Marrow Donor Program. Blood. 2004;103:1955-1960.
    • (2004) Blood , vol.103 , pp. 1955-1960
    • Izutsu, K.1    Kanda, Y.2    Ohno, H.3
  • 8
    • 6444227274 scopus 로고    scopus 로고
    • Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors
    • The Japan Society for Hematopoietic Cell Transplantation Working Party
    • Kameoka I, Kami M, Takahashi S, et al. Clinical impact of graft-versus-host disease against leukemias not in remission at the time of allogeneic hematopoietic stem cell transplantation from related donors. The Japan Society for Hematopoietic Cell Transplantation Working Party. Bone Marrow Transplant. 2004;34:711-719.
    • (2004) Bone Marrow Transplant , vol.34 , pp. 711-719
    • Kameoka, I.1    Kami, M.2    Takahashi, S.3
  • 9
    • 0029742950 scopus 로고    scopus 로고
    • Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: Analysis of engraftment and acute graft-versus-host disease
    • Wagner JE, Rosenthal J, Sweetman R, et al. Successful transplantation of HLA-matched and HLA-mismatched umbilical cord blood from unrelated donors: analysis of engraftment and acute graft-versus-host disease. Blood. 1996;88:795-802.
    • (1996) Blood , vol.88 , pp. 795-802
    • Wagner, J.E.1    Rosenthal, J.2    Sweetman, R.3
  • 10
    • 2542599392 scopus 로고    scopus 로고
    • Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases
    • Miyakoshi S, Yuji K, Kami M, et al. Successful engraftment after reduced-intensity umbilical cord blood transplantation for adult patients with advanced hematological diseases. Clin Cancer Res. 2004;10:3586-3592.
    • (2004) Clin Cancer Res , vol.10 , pp. 3586-3592
    • Miyakoshi, S.1    Yuji, K.2    Kami, M.3
  • 11
    • 0031473846 scopus 로고    scopus 로고
    • Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango
    • Madrigal JA, Cohen SB, Gluckman E, Charron DJ. Does cord blood transplantation result in lower graft-versus-host disease? It takes more than two to tango. Hum Immunol. 1997;56:1-5.
    • (1997) Hum Immunol , vol.56 , pp. 1-5
    • Madrigal, J.A.1    Cohen, S.B.2    Gluckman, E.3    Charron, D.J.4
  • 12
    • 0024451005 scopus 로고
    • Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: Possible role of genetic homogeneity
    • The Nagoya Bone Marrow Transplantation Group
    • Morishima Y, Morishita Y, Tanimoto M, et al. Low incidence of acute graft-versus-host disease by the administration of methotrexate and cyclosporine in Japanese leukemia patients after bone marrow transplantation from human leukocyte antigen compatible siblings: possible role of genetic homogeneity. The Nagoya Bone Marrow Transplantation Group. Blood. 1989;74:2252-2256.
    • (1989) Blood , vol.74 , pp. 2252-2256
    • Morishima, Y.1    Morishita, Y.2    Tanimoto, M.3
  • 13
    • 0032558686 scopus 로고    scopus 로고
    • Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor
    • Sasazuki T, Juji T, Morishima Y, et al. Effect of matching of class I HLA alleles on clinical outcome after transplantation of hematopoietic stem cells from an unrelated donor. N Engl J Med. 1998;339:1177-1185.
    • (1998) N Engl J Med , vol.339 , pp. 1177-1185
    • Sasazuki, T.1    Juji, T.2    Morishima, Y.3
  • 14
    • 0029164624 scopus 로고
    • The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation
    • Petersdorf EW, Longton GM, Anasetti C, et al. The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation. Blood. 1995;86:1606-1613.
    • (1995) Blood , vol.86 , pp. 1606-1613
    • Petersdorf, E.W.1    Longton, G.M.2    Anasetti, C.3
  • 15
    • 0036625047 scopus 로고    scopus 로고
    • The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors
    • Morishima Y, Sasazuki T, Inoko H, et al. The clinical significance of human leukocyte antigen (HLA) allele compatibility in patients receiving a marrow transplant from serologically HLA-A, HLA-B, and HLA-DR matched unrelated donors. Blood. 2002;99:4200-4206.
    • (2002) Blood , vol.99 , pp. 4200-4206
    • Morishima, Y.1    Sasazuki, T.2    Inoko, H.3
  • 16
    • 0028889993 scopus 로고
    • Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia
    • Zittoun RA, Mandelli F, Willemze R, et al, for the European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne del-1'Adulto (GIMEMA) Research Cooperative Groups. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. N Engl J Med. 1995;332:217-223.
    • (1995) N Engl J Med , vol.332 , pp. 217-223
    • Zittoun, R.A.1    Mandelli, F.2    Willemze, R.3
  • 17
    • 0032492441 scopus 로고    scopus 로고
    • Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: Results of MRCAML10 trial
    • Burnett AK, Goldstone AH, Stevens RMF, et al, for the UK Medical Research Council Adult and Children's Leukaemia Working Parties. Randomised comparison of addition of autologous bone-marrow transplantation to intensive chemotherapy for acute myeloid leukaemia in first remission: results of MRCAML10 trial. Lancet. 1998;351:700-708.
    • (1998) Lancet , vol.351 , pp. 700-708
    • Burnett, A.K.1    Goldstone, A.H.2    Rmf, S.3
  • 18
    • 0032480930 scopus 로고    scopus 로고
    • Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission
    • Cassileth PA, Harrington DP, Appelbaum FR, et al. Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission. N Engl J Med. 1998;339:1649-1666.
    • (1998) N Engl J Med , vol.339 , pp. 1649-1666
    • Cassileth, P.A.1    Harrington, D.P.2    Appelbaum, F.R.3
  • 19
    • 0030831841 scopus 로고    scopus 로고
    • Autologous peripheral stem cell transplantation for acute myelogenous leukemia
    • Gondo H, Harada M, Miyamoto T, et al. Autologous peripheral stem cell transplantation for acute myelogenous leukemia. Bone Marrow Transplant. 1997;20:821-826.
    • (1997) Bone Marrow Transplant , vol.20 , pp. 821-826
    • Gondo, H.1    Harada, M.2    Miyamoto, T.3
  • 20
    • 7044263031 scopus 로고    scopus 로고
    • Outcome of treatment in adults with acute lymphoblastic leukemia: Analysis of the LALA-94 trial
    • Thomas X, Boiron J-M, Huguet F, et al. Outcome of treatment in adults with acute lymphoblastic leukemia: analysis of the LALA-94 trial. J Clin Oncol. 2004;22:4075-4086.
    • (2004) J Clin Oncol , vol.22 , pp. 4075-4086
    • Thomas, X.1    Boiron, J.-M.2    Huguet, F.3
  • 21
    • 4344682975 scopus 로고    scopus 로고
    • Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: No difference in related compared with unrelated transplant in first complete remission
    • Kiehl MG, Kraut L, Schwerdtfeger R, et al. Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remission. J Clin Oncol. 2004;22:2816-2825.
    • (2004) J Clin Oncol , vol.22 , pp. 2816-2825
    • Kiehl, M.G.1    Kraut, L.2    Schwerdtfeger, R.3
  • 22
    • 1342266375 scopus 로고    scopus 로고
    • Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia
    • Nordlander A, Mattsson J, Ringden O, et al. Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia. Biol Blood Marrow Transplant. 2004;10:195-203.
    • (2004) Biol Blood Marrow Transplant , vol.10 , pp. 195-203
    • Nordlander, A.1    Mattsson, J.2    Ringden, O.3
  • 23
    • 0036163711 scopus 로고    scopus 로고
    • Autologous stem cell transplantation in acute lymphocytic leukemia
    • Gorin NC. Autologous stem cell transplantation in acute lymphocytic leukemia. Stem Cells. 2002;20:3-10.
    • (2002) Stem Cells , vol.20 , pp. 3-10
    • Gorin, N.C.1
  • 25
    • 0029952614 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for CML: A report from the International Bone Marrow Transplant Registry
    • Horowitz MM, Rowlings PA, Passweg JR. Allogeneic bone marrow transplantation for CML: a report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant. 1996;17(suppl 3):S5-S6.
    • (1996) Bone Marrow Transplant , vol.17 , Issue.SUPPL. 3
    • Horowitz, M.M.1    Rowlings, P.A.2    Passweg, J.R.3
  • 26
    • 0008947293 scopus 로고    scopus 로고
    • Bone marrow transplants from unrelated donors of patients with chronic myeloid leukemia
    • Hansen JA, Gooley TA, Martin PJ, et al. Bone marrow transplants from unrelated donors of patients with chronic myeloid leukemia. N Engl J Med. 1998;338:962-968.
    • (1998) N Engl J Med , vol.338 , pp. 962-968
    • Hansen, J.A.1    Gooley, T.A.2    Martin, P.J.3
  • 27
    • 0035313619 scopus 로고    scopus 로고
    • Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors
    • Davies SM, DeFor TE, McGlave PB, et al. Equivalent outcomes in patients with chronic myelogenous leukemia after early transplantation of phenotypically matched bone marrow from related or unrelated donors. Am J Med. 2001;110:339-346.
    • (2001) Am J Med , vol.110 , pp. 339-346
    • Davies, S.M.1    DeFor, T.E.2    McGlave, P.B.3
  • 28
    • 0031756617 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplantation for myelodysplastic syndrome: Outcomes analysis according to IPSS score
    • Appelbaum FR, Anderson A. Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score. Leukemia. 1998;12(suppl 1):S25-S29.
    • (1998) Leukemia , vol.12 , Issue.SUPPL. 1
    • Appelbaum, F.R.1    Anderson, A.2
  • 29
    • 0031961981 scopus 로고    scopus 로고
    • Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: Early transplantation is associated with improved outcome
    • Runde V, de Witte T, Arnold R, et al, on behalf of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Bone Marrow Transplant. 1998;21:255-261.
    • (1998) Bone Marrow Transplant , vol.21 , pp. 255-261
    • Runde, V.1    De Witte, T.2    Arnold, R.3
  • 30
    • 0037105374 scopus 로고    scopus 로고
    • Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia
    • Sierra J, Perez WS, Rozman C, et al. Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia. Blood. 2002;200:1997-2004.
    • (2002) Blood , vol.200 , pp. 1997-2004
    • Sierra, J.1    Perez, W.S.2    Rozman, C.3
  • 31
    • 0037085746 scopus 로고    scopus 로고
    • Unrelated donor marrow transplantation for myelodysplastic syndromes: Outcome analysis in 510 transplants facilitated by the National Marrow Donor Program
    • Castro-Malaspina H, Harris RE, Gajewski J, et al. Unrelated donor marrow transplantation for myelodysplastic syndromes: outcome analysis in 510 transplants facilitated by the National Marrow Donor Program. Blood. 2002;99:1943-1951.
    • (2002) Blood , vol.99 , pp. 1943-1951
    • Castro-Malaspina, H.1    Harris, R.E.2    Gajewski, J.3
  • 32
    • 0024215995 scopus 로고    scopus 로고
    • Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: A report of the BMT Working Party
    • Bacigalupo A, Hows J, Gordon-Smith EC, et al. Bone marrow transplantation for severe aplastic anemia from donors other than HLA identical siblings: a report of the BMT Working Party. Bone Marrow Transplant. 1998;3:531-535.
    • (1998) Bone Marrow Transplant , vol.3 , pp. 531-535
    • Bacigalupo, A.1    Hows, J.2    Gordon-Smith, E.C.3
  • 33
    • 0026694857 scopus 로고
    • Unrelated donor marrow transplants for severe acquired aplastic anemia
    • Hows JM, Szydlo R, Anasetti C, et al. Unrelated donor marrow transplants for severe acquired aplastic anemia. Bone Marrow Transplant. 1992;10:102-106.
    • (1992) Bone Marrow Transplant , vol.10 , pp. 102-106
    • Hows, J.M.1    Szydlo, R.2    Anasetti, C.3
  • 34
    • 0027526116 scopus 로고
    • Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program
    • Keran NA, Bartsh G, Ash RC, et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med. 1993;328:593-602.
    • (1993) N Engl J Med , vol.328 , pp. 593-602
    • Keran, N.A.1    Bartsh, G.2    Ash, R.C.3
  • 35
    • 0036682485 scopus 로고    scopus 로고
    • Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: The Japan Marrow Donor Program
    • Kojima S, Matsuyama T, Kato S, et al. Outcome of 154 patients with severe aplastic anemia who received transplants from unrelated donors: the Japan Marrow Donor Program. Blood. 2002;100:799-803.
    • (2002) Blood , vol.100 , pp. 799-803
    • Kojima, S.1    Matsuyama, T.2    Kato, S.3
  • 36
    • 0032533228 scopus 로고    scopus 로고
    • Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient
    • Petersdorf EW, Gooley TA, Anasetti C, et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient. Blood. 1998;92:3515-3520.
    • (1998) Blood , vol.92 , pp. 3515-3520
    • Petersdorf, E.W.1    Gooley, T.A.2    Anasetti, C.3
  • 37
    • 12144289116 scopus 로고    scopus 로고
    • Long-term outcome after bone marrow transplantation for severe aplastic anemia
    • Ades L, Mary JY, Robin M, et al. Long-term outcome after bone marrow transplantation for severe aplastic anemia. Blood. 2004;103:2490-2497.
    • (2004) Blood , vol.103 , pp. 2490-2497
    • Ades, L.1    Mary, J.Y.2    Robin, M.3
  • 38
    • 0028790440 scopus 로고
    • Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma
    • Philip T, Guglielmi C, Hagenbeek A, et al. Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin's lymphoma. N Engl J Med. 1995;333:1540-1545.
    • (1995) N Engl J Med , vol.333 , pp. 1540-1545
    • Philip, T.1    Guglielmi, C.2    Hagenbeek, A.3
  • 39
    • 0031953768 scopus 로고    scopus 로고
    • High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma
    • Vose J. High-dose chemotherapy and hematopoietic stem cell transplantation for relapsed or refractory diffuse large-cell non-Hodgkin's lymphoma. Ann Oncol. 1998;9(suppl 1):S1-S3.
    • (1998) Ann Oncol , vol.9 , Issue.SUPPL. 1
    • Vose, J.1
  • 40
    • 0032951328 scopus 로고    scopus 로고
    • International Consensus Conference on High-Dose Therapy in Aggressive Non-Hodgkin's Lymphomas: Report of the jury
    • Shipp MA, Abeloff MD, Antman KH, et al. International Consensus Conference on High-Dose Therapy in Aggressive Non-Hodgkin's Lymphomas: report of the jury. J Clin Oncol. 1999;17:423-429.
    • (1999) J Clin Oncol , vol.17 , pp. 423-429
    • Shipp, M.A.1    Abeloff, M.D.2    Antman, K.H.3
  • 41
    • 23744478874 scopus 로고    scopus 로고
    • Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: A retrospective survey of 112 adult patients in Japan
    • Kusumi E, Kami M, Kanda Y, et al. Reduced-intensity hematopoietic stem-cell transplantation for malignant lymphoma: a retrospective survey of 112 adult patients in Japan. Bone Marrow Transplant. 2005;36:205-213.
    • (2005) Bone Marrow Transplant , vol.36 , pp. 205-213
    • Kusumi, E.1    Kami, M.2    Kanda, Y.3
  • 42
    • 0037767207 scopus 로고    scopus 로고
    • Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma
    • Hosing C, Saliba RM, McLaughlin P, et al. Long-term results favor allogeneic over autologous hematopoietic stem cell transplantation in patients with refractory or recurrent indolent non-Hodgkin's lymphoma. Ann Oncol. 2003;14:737-744.
    • (2003) Ann Oncol , vol.14 , pp. 737-744
    • Hosing, C.1    Saliba, R.M.2    McLaughlin, P.3
  • 43
    • 0035575850 scopus 로고    scopus 로고
    • Long-term results of blood and marrow transplantation for Hodgkin's lymphoma
    • Akpek G, Ambinder RF, Piantadosi S, et al. Long-term results of blood and marrow transplantation for Hodgkin's lymphoma. J Clin Oncol. 2001;23:4314-4321.
    • (2001) J Clin Oncol , vol.23 , pp. 4314-4321
    • Akpek, G.1    Ambinder, R.F.2    Piantadosi, S.3
  • 44
    • 9044237273 scopus 로고    scopus 로고
    • Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease
    • Gajewski JL, Phillips GL, Sobocinski KA, et al. Bone marrow transplants from HLA-identical siblings in advanced Hodgkin's disease. J Clin Oncol. 1996;14:572-578.
    • (1996) J Clin Oncol , vol.14 , pp. 572-578
    • Gajewski, J.L.1    Phillips, G.L.2    Sobocinski, K.A.3
  • 45
    • 0030008082 scopus 로고    scopus 로고
    • Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease: European Group for Blood and Bone Marrow Transplantation
    • Milpied N, Fielding AK, Pearce RM, Ernst P, Goldstone AH. Allogeneic bone marrow transplant is not better than autologous transplant for patients with relapsed Hodgkin's disease: European Group for Blood and Bone Marrow Transplantation. J Clin Oncol. 1996;14:1291-1296.
    • (1996) J Clin Oncol , vol.14 , pp. 1291-1296
    • Milpied, N.1    Fielding, A.K.2    Pearce, R.M.3    Ernst, P.4    Goldstone, A.H.5
  • 46
    • 0028194968 scopus 로고
    • High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma
    • Cunningham DH, Paz-Ares L, Milan S, et al. High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma. J Clin Oncol. 1994;12:759-763.
    • (1994) J Clin Oncol , vol.12 , pp. 759-763
    • Cunningham, D.H.1    Paz-Ares, L.2    Milan, S.3
  • 47
    • 8944220233 scopus 로고    scopus 로고
    • A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma: Intergroupe Francais du Myelome
    • Attal M, Harousseau JL, Stoppa AM, et al. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma: Intergroupe Francais du Myelome. N Engl J Med. 1996;335:91-97.
    • (1996) N Engl J Med , vol.335 , pp. 91-97
    • Attal, M.1    Harousseau, J.L.2    Stoppa, A.M.3
  • 48
    • 0037739753 scopus 로고    scopus 로고
    • High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma
    • Child J, Morgan G, Davies F, et al, for the Medical Research Council Adult Leukaemia Working Party. High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma. N Engl J Med. 2003;348:1875-1883.
    • (2003) N Engl J Med , vol.348 , pp. 1875-1883
    • Child, J.1    Morgan, G.2    Davies, F.3
  • 49
    • 0034894245 scopus 로고    scopus 로고
    • Allogeneic hematopoietic cell transplantation for multiple myeloma
    • Bensinger W, Maloney D, Storb R. Allogeneic hematopoietic cell transplantation for multiple myeloma. Semin Hematol. 2001;38:243-249.
    • (2001) Semin Hematol , vol.38 , pp. 243-249
    • Bensinger, W.1    Maloney, D.2    Storb, R.3
  • 50
    • 0031001279 scopus 로고    scopus 로고
    • Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma
    • Barlogie B, Jagannath S, Vesole D, et al. Superiority of tandem autologous transplantation over standard therapy for previously untreated multiple myeloma. Blood. 1997;89:789-793.
    • (1997) Blood , vol.89 , pp. 789-793
    • Barlogie, B.1    Jagannath, S.2    Vesole, D.3
  • 51
    • 0036498782 scopus 로고    scopus 로고
    • Improved outcome of non-myeloablative allogeneic transplantation in multiple myeloma
    • Bardos A, Barlogie B, Siegel E, et al. Improved outcome of non-myeloablative allogeneic transplantation in multiple myeloma. J Clin Oncol. 2002;20:1295-1303.
    • (2002) J Clin Oncol , vol.20 , pp. 1295-1303
    • Bardos, A.1    Barlogie, B.2    Siegel, E.3
  • 52
    • 0142152420 scopus 로고    scopus 로고
    • Allografting with non-myeloablative conditioning following cytoreductive autografting for the treatment of patients with multiple myeloma
    • Maloney DG, Molina AJ, Sahebi F, et al. Allografting with non-myeloablative conditioning following cytoreductive autografting for the treatment of patients with multiple myeloma. Blood. 2003;102:3447-3454.
    • (2003) Blood , vol.102 , pp. 3447-3454
    • Maloney, D.G.1    Molina, A.J.2    Sahebi, F.3
  • 53
  • 54
    • 0034648702 scopus 로고    scopus 로고
    • Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation
    • Childs R, Chemoff A, Contentin N, et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med. 2000;343:750-758.
    • (2000) N Engl J Med , vol.343 , pp. 750-758
    • Childs, R.1    Chemoff, A.2    Contentin, N.3
  • 55
    • 0242578094 scopus 로고    scopus 로고
    • Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors
    • Ueno NT, Cheng YC, Rondon G, et al. Rapid induction of complete donor chimerism by the use of a reduced-intensity conditioning regimen composed of fludarabine and melphalan in allogeneic stem cell transplantation for metastatic solid tumors. Blood. 2003;102:3829-3836.
    • (2003) Blood , vol.102 , pp. 3829-3836
    • Ueno, N.T.1    Cheng, Y.C.2    Rondon, G.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.